Repurposed Drug Reduces Agitation in Alzheimer’s Patients
Friday, October 16, 2015 - 09:00
in Health & Medicine
A recent study found that a drug currently marketed under the trade name Nuedexta, which is approved by the Federal Drug Administration to treat pseudobulbar affect, a neurologic disorder defined by uncontrolled emotional responses, may also reduce agitation in patients with Alzheimer’s disease. The study, which was published in the Journal of the American Medical […]